INVESTOR ALERT: Investigation of Bellerophon Therapeutics, Inc. Announced by Law Offices of Howard G. Smith
October 28 2016 - 12:19PM
Business Wire
Law Offices of Howard G. Smith announces an investigation
on behalf of investors of Bellerophon Therapeutics, Inc.
(“Bellerophon” or the “Company”) (NASDAQ: BLPH) concerning the
Company and its officers’ possible violations of federal securities
laws.
Bellerophon is a clinical-stage therapeutics company that
focuses on the development of products at the intersection of drugs
and devices that address unmet medical needs in the treatment of
cardiopulmonary diseases.
On February 13, 2015, Bellerophon sold 13 million shares of
stock in its initial public stock offering (the "IPO"). Since
the IPO however, shares of Bellerophon stock have fallen sharply,
after the Company reported poor operating results and certain
executive changes.
If you purchased Bellerophon securities, have information or
would like to learn more about these claims, or have any questions
concerning this announcement or your rights or interests with
respect to these matters, please contact Howard G. Smith, Esquire,
of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847,
toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161028005701/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Bellerophon Therapeutics (NASDAQ:BLPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bellerophon Therapeutics (NASDAQ:BLPH)
Historical Stock Chart
From Apr 2023 to Apr 2024
